Pharma
One Nucleus + Elevate by Longfellow: Breakfast & Brilliance
On Wednesday, 15 October, One Nucleus is partnering with Longfellow to host the very first Elevate event at the newly completed Cam3 building on the CamLIFE campus in Cambridge.Titled Breakfast and Brilliance, the morning will offer just that: a delicious breakfast, opportunities to con...
The 15-year warning: Why we need to measure lung decline in traffic jams, not clinic waiting rooms
Insights from Bipin Patel, CEO & Founder
Reactive to predictive: potential of lung age for chronic disease management
Insights from Bipin Patel, CEO & FounderWe ask COPD patients to travel to hospitals when they're breathless, perform forced breathing manoeuvres when they're exhausted, and remember to schedule follow-up appointments three to six months hence, when, quite frankly, they've prob...
CJ & L Consultancy to launch ‘Rent an eQMS’ – A ready-to-use Compliance Solution on 1st November 2025
Start-ups and small businesses can now access a fully functioning Electronic Quality Management System (eQMS) without the heavy investment of building one in-house. Designed to meet ISO 9001, 13485, 27001, and 45001, our eQMS is adaptable, secure, and available immediately — so you can...
Frontiers in Stem Cell Innovation 2026
The Frontiers in Stem Cell Innovation Conference 2026 will bring together leading academic and industry expertise in stem cell research to explore the breakthrough technologies and translational developments that are transforming drug discovery and therapeutic development. ...
Webinar - A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2
We invite you to join us on Wednesday 22nd October for an insightful webinar where we use a new TYK2 benchmark dataset to test the predictive abilities of Free Energy Perturbation (FEP). ...
Guardtech support staff member’s epic trek for cancer charity close to the business’ heart
The Haverhill cleanroom construction specialists donated £500 to Sarcoma UK to support their IT & Systems Manager Elliott Sheppard’s 25km trek in honour of his daughter Isobel ...
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"). Arecor Therapeutics plc(“Arecor” or the “Company”)Co-development Agreement with US Insulin Pump Device Company for AT...
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. ...
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemicCOPD is a silent killer. It is the third leading cause of death worldwide, taking three million lives annually. More than 450 million are diagnosed, and the actual number may reach 900 million when undiagnosed cases are counted. In the EU, COPD costs €38.6 billion annua...